The Muha Meds Master case continues to draw significant attention from authorities, revealing a intricate network of alleged fraud. Initial findings suggested a simple billing discrepancy, but a deeper look uncovered a widespread operation involving several individuals and potentially billions of funds. The probe has targeted on suspicious practice